Evidence mapPaperPMID 39064697Full record

Trial reportNutrients2024

The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled Trial.

Eunbyul Cho, Sunwoo Kim, Soonkyu Kim, Ju Young Kim, Hwa Jung Kim, Yumi Go, Yu Jung Lee, Haesol Lee, Siye Gil, Sung Kwon Yoon and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eunbyul ChoDepartment of Family Medicine, Seoul National University Bundang Hospital, Seongnam-si 13620, Republic of Korea.
Sunwoo KimHealth Promotion Center, Seoul Bumin Hospital, Seoul 07590, Republic of Korea.
Soonkyu KimHealth Promotion Center, Seoul Bumin Hospital, Seoul 07590, Republic of Korea.
Ju Young KimBionutrion Corp., Seoul 06097, Republic of Korea.ORCID 0000-0001-6018-3337
Hwa Jung KimDepartment of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.ORCID 0000-0003-1916-7014
Yumi GoBionutrion Corp., Seoul 06097, Republic of Korea.
Yu Jung LeeBionutrion Corp., Seoul 06097, Republic of Korea.
Haesol LeeBionutrion Corp., Seoul 06097, Republic of Korea.
Siye GilBionutrion Corp., Seoul 06097, Republic of Korea.
Sung Kwon YoonBionutrion Corp., Seoul 06097, Republic of Korea.
Keonho ChuBionutrion Corp., Seoul 06097, Republic of Korea.ORCID 0009-0003-5357-7241

Funding

Korean National IT Industry Promotion Agency. 2023 Lifestyle digital leading service project
6 · The paper itself

Abstract

While many studies have explored dietary substitutes and mobile apps separately, a combined approach to metabolic dysfunction-associated steatotic liver disease (MASLD) has not been investigated. This study evaluated short-term mobile interventions coupled with partial meal replacement in patients with MASLD. Sixty adults with MASLD and a body mass index ≥25 kg/m

Indexed as

Alanine TransaminaseDiet, High-ProteinLiverMobile ApplicationsAdultAgedAspartate AminotransferasesBody Mass IndexFatty LiverFemalegamma-GlutamyltransferaseHumansLife StyleLiver Function TestsMaleMealsAlanine TransaminaseAspartate Aminotransferasesgamma-Glutamyltransferasedigital health technologiesmeal replacementmetabolic dysfunction-associated steatotic liver diseasemobile interventionobesity

Identifiers

PMID39064697
PMCPMC11279924

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.